ABG Oxidative Stress Study Protocol-1

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

December 31, 2013

Conditions
Healthy
Interventions
DIETARY_SUPPLEMENT

Plant concentrate A

Screening for the optimal dosage by starting with with a low dose of 300 mg for one week then switch to 600 mg for one week.

DIETARY_SUPPLEMENT

Plant concentrate B

Screening for the optimal dosage by starting with with a low dose of 300 mg for one week then switch to 600 mg for one week.

DIETARY_SUPPLEMENT

Plant concentrate C

Screening for the optimal dosage by starting with with a low dose of 300 mg for one week then switch to 600 mg for one week.

DIETARY_SUPPLEMENT

Plant concentrate D

Screening for the optimal dosage by starting with with a low dose of 300 mg for one week then switch to 600 mg for one week.

Trial Locations (2)

90620

Quality of Life, Buena Park

Southbay Pharma Research, Buena Park

All Listed Sponsors
lead

Access Business Group

INDUSTRY

NCT02213523 - ABG Oxidative Stress Study Protocol-1 | Biotech Hunter | Biotech Hunter